Additional analysis demonstrated that average expression levels of SP1, DKK1, and FGR significantly predicted post-progression survival in CRC, with an HR of 2.87 (95% CI: 1.35–6.1, log-rank P = 0.0041) (Fig. 7D). This evidence concerns the gene DKK1 and colorectal carcinoma.